The Cutting Edge of Healthcare: China's Advances in Medical Tech
VIDEO
Disruptive Technologies Case Study
Chinese hospital improves hospital care with 5G
WSI Technologies Case Study: An Interview with Jim Halsmer
Worn Again Technologies Case Study
Two-year-old rescued from well in China using iPhone
Made in China: "Capsule robot" in gastric diagnosis
COMMENTS
China's data-driven dream to overhaul health care
According to the company, the platform gives around 400,000 of these auxiliary opinions each day in as many as 30,000 medical institutions. Many of China's technology giants, including Alibaba ...
China's medical-device industry gets a makeover
The strategy is affecting both China's medical-device sector and the medical-technology industry as a whole. Medical technology includes devices that use information technology to detect ...
China sets the pace in adoption of AI in healthcare technology
Beijing's policymakers have thrown their support behind medical AI companies that come up with technological innovations to ease the burden on the country's hospital system. Medical and health ...
PDF Investigating state support for China's medical technology companies
Distortions in the medical technology sector flourish due to growing policy support The government is committed to advancing local industrial capabilities in this prominent, high-tech sector, which remains dominated by foreign suppliers. Consequently, high-end medical devices featured among the Made in China 2025 key industries released in 2015 .
Upgrading medtech commercial operations in China
China's burgeoning market for medtech, estimated at $70 billion in 2021, 1 Based on McKinsey analysis of National Health Commission (NHC) data and annual reports regarding revenue of more than 150 medtech companies and their market share. could more than double this decade if the government's Healthy China 2030 plan stays on track. The plan projects 9 percent annual spending growth through ...
Building an innovation system of medical devices in China: Drivers
This study applied a qualitative case study by identifying the medical device sector in China as a whole case. 23,24. Data collection. Data and materials were collected from multiple sources. First, official data and policy documents were collected from the China Food and Drug Administration (CFDA) and the General Administration of Customs ...
China's rising star of medical innovation
It is the first hospital in northeast China to use the robotic da Vinci Surgical System to remove bile duct cysts. "Our global research recruits will join other top scientists in our hospital to ...
Accelerating Medical Device Innovation in China
Speeding Heart-Valve Development. It took a decade for Venus A, Venus Med Tech's first generation of domestically produced transcatheter valves, to receive CFDA approval for sale in 2017. Since its approval, the company has sold 1,010 units in China, representing total revenue of RMB ¥240,000,000 (USD $36 million).
The experience and challenges of healthcare-reform-driven medical
The experience and challenges of healthcare-reform-driven medical consortia and Regional Health Information Technologies in China: A longitudinal study Int J Med Inform . 2019 Nov:131:103954. doi: 10.1016/j.ijmedinf.2019.103954.
How health technology reassessment can support disinvestment in China's
Health technology assessment (HTA), including pharmacoeconomic evaluation guidelines, has contributed to 30 years of evidence informed decision making in China, most recently as part of analyses to support price negotiation for medicines added to the reimbursement list in 2017 and 2019.4
Development and evolution of medical technology management in China
And the development and evolution on the policies and regulations of medical technology management in China can be mainly divided into four stages: before 2009, 2009-2015, 2015-2018, 2018-present. Before 2009, only a few individual medical technologies (such as the transplantation of hematopoietic stem cells, reproductive assistant ...
Internationalization of China's medical device industry: a case study
Regardless of these limitations, the study provided an intriguing case of a Chinese company's internationalization to Brazil, operating in a high-tech medical sector. The challenges for EMNCs' internationalization continue, which makes more research in this area timely. However, our findings can be the first step.
Investigating state support for China's medical technology companies
Medical technologies are a key focus of China's industrial policy strategy and central to Beijing's plans to move up the value chain. To spur on the development of local firms and promote self-reliance in this highly innovative sector, Chinese officials are steering research into key technologies and offering financial assistance to promising firms. In addition, biased procurement processes ...
Mapping of health technology assessment in China: a comparative study
Background Health Technology Assessment (HTA) in China has recently expanded from purely academic research to include policy or decision-oriented practice, especially after HTA evidence was used to update the National Reimbursement Drug List for the first time in 2017. This study aims to identify the progress and challenges of HTA development from 2016 to 2021 and inform policies and decisions ...
EU targets China medical technology market with launch of new
China's medical technology market was estimated to be worth US$144.5 billion in 2022, according to a study by the Mercator Institute for China Studies, a Berlin think tank that has been ...
Evaluation of Privacy Risks of Patients' Data in China: Case Study
1 Digital China Health Technologies Corporation Limited, Beijing, China 2 ... Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China ... the proposed studies still have a few limitations. First, the privacy risk that we estimated for the case study is based on the cancer patients' data without including patients ...
Assessing quality of direct-to-consumer telemedicine in China: a cross
Direct-to-onsumer telemedicine (DTCT) has become popular as an alternative to traditional care. However, uncertainties about the potential risks associated with the lack of comprehensive quality evaluation could influence its long-term development. This study aimed to assess the quality of care provided by DTCT platforms in China using unannounced standardised patients (USP) between July 2021 ...
Building an innovation system of medical devices in China: Drivers
The development of medical device sector in China has attracted much attention from around the world due to the nation's huge market and rising research and development (R&D) capabilities. 1,2 The sales of medical devices in China totaled no more than CNY 14.5 billion in 2000, but increased to CNY 308 billion in 2015. Since 2013, China has been ranked as the second-largest medical device ...
Artificial Intelligence Technologies in Medicine: Case Studies from
According to Omdia research, Chinese startups raised $1.4 billion in funding in 2020 alone, compared to their US counterparts' $2.4 billion, and the two countries accounted for 90 per cent of global investment in medical AI startups. One notable case study is the utilization of AI in cancer diagnosis at Beijing's National Cancer Center.
An early assessment of the County Medical Community reform in China: a
He received his B.S. in Computer Science and Technology from Zhejiang University in 2005, and Ph.D. in Computer Science and Technology from Zhejiang University and Imperial College London in 2010. After Ph.D., he worked as a Research Associate and then Research Fellow in the Department of Computing, Imperial College London until 2017.
China Medical Technologies
China Medical Technologies, Inc. (CMED) was a Cayman Islands corporation based in China, currently in liquidation following fraud allegations. It purported to develop, manufacture, and market advanced in vitro diagnostic ("IVD") products using enhanced chemiluminescence ("ECLIA") technology, fluorescent in-situ hybridization ("FISH") technology, and surface plasmon resonance ("SPR ...
Europe Hits China With Medical Devices Probe Before Xi Visit
The European Union launched an investigation into China's procurement of medical devices, the latest in a spate of actions that are raising tension ahead of President Xi Jinping's first visit ...
KPMG hit by Hong Kong High Court in $400 million China Medical fraud
The China Medical case is the most high-profile and closely watched contest in years over the production of Chinese audit work papers, an issue that has put Hong Kong and U.S. regulators at ...
Medical technology case studies
A medical device manufacturer sharpens pricing and contracting strategies with analytics. ZS helped a multinational medical supplies manufacturer prioritize analytics in the P&C space and take advantage of deeper business insights, leading to more data-driven and effective commercial strategies to increase profitability. Read on.
EU launches probe into China's public procurement of medical devices
According to the trade association, China is one of the major trading partners for medical equipment in Europe, making up 11% of the market's export destinations in 2022. Tough on China
Pump-probe high-harmonic spectroscopy could catch geometric phase
A collaborative research team from Nanjing University of Science and Technology (NJUST) and East China Normal University (ECNU) has theoretically proposed that a pump-probe high-harmonic ...
Trends in electric cars
Electric car sales neared 14 million in 2023, 95% of which were in China, Europe and the United States. Almost 14 million new electric cars1 were registered globally in 2023, bringing their total number on the roads to 40 million, closely tracking the sales forecast from the 2023 edition of the Global EV Outlook (GEVO-2023). Electric car sales in 2023 were 3.5 million higher than in 2022, a 35 ...
IMAGES
VIDEO
COMMENTS
According to the company, the platform gives around 400,000 of these auxiliary opinions each day in as many as 30,000 medical institutions. Many of China's technology giants, including Alibaba ...
The strategy is affecting both China's medical-device sector and the medical-technology industry as a whole. Medical technology includes devices that use information technology to detect ...
Beijing's policymakers have thrown their support behind medical AI companies that come up with technological innovations to ease the burden on the country's hospital system. Medical and health ...
Distortions in the medical technology sector flourish due to growing policy support The government is committed to advancing local industrial capabilities in this prominent, high-tech sector, which remains dominated by foreign suppliers. Consequently, high-end medical devices featured among the Made in China 2025 key industries released in 2015 .
China's burgeoning market for medtech, estimated at $70 billion in 2021, 1 Based on McKinsey analysis of National Health Commission (NHC) data and annual reports regarding revenue of more than 150 medtech companies and their market share. could more than double this decade if the government's Healthy China 2030 plan stays on track. The plan projects 9 percent annual spending growth through ...
This study applied a qualitative case study by identifying the medical device sector in China as a whole case. 23,24. Data collection. Data and materials were collected from multiple sources. First, official data and policy documents were collected from the China Food and Drug Administration (CFDA) and the General Administration of Customs ...
It is the first hospital in northeast China to use the robotic da Vinci Surgical System to remove bile duct cysts. "Our global research recruits will join other top scientists in our hospital to ...
Speeding Heart-Valve Development. It took a decade for Venus A, Venus Med Tech's first generation of domestically produced transcatheter valves, to receive CFDA approval for sale in 2017. Since its approval, the company has sold 1,010 units in China, representing total revenue of RMB ¥240,000,000 (USD $36 million).
The experience and challenges of healthcare-reform-driven medical consortia and Regional Health Information Technologies in China: A longitudinal study Int J Med Inform . 2019 Nov:131:103954. doi: 10.1016/j.ijmedinf.2019.103954.
Health technology assessment (HTA), including pharmacoeconomic evaluation guidelines, has contributed to 30 years of evidence informed decision making in China, most recently as part of analyses to support price negotiation for medicines added to the reimbursement list in 2017 and 2019.4
And the development and evolution on the policies and regulations of medical technology management in China can be mainly divided into four stages: before 2009, 2009-2015, 2015-2018, 2018-present. Before 2009, only a few individual medical technologies (such as the transplantation of hematopoietic stem cells, reproductive assistant ...
Regardless of these limitations, the study provided an intriguing case of a Chinese company's internationalization to Brazil, operating in a high-tech medical sector. The challenges for EMNCs' internationalization continue, which makes more research in this area timely. However, our findings can be the first step.
Medical technologies are a key focus of China's industrial policy strategy and central to Beijing's plans to move up the value chain. To spur on the development of local firms and promote self-reliance in this highly innovative sector, Chinese officials are steering research into key technologies and offering financial assistance to promising firms. In addition, biased procurement processes ...
Background Health Technology Assessment (HTA) in China has recently expanded from purely academic research to include policy or decision-oriented practice, especially after HTA evidence was used to update the National Reimbursement Drug List for the first time in 2017. This study aims to identify the progress and challenges of HTA development from 2016 to 2021 and inform policies and decisions ...
China's medical technology market was estimated to be worth US$144.5 billion in 2022, according to a study by the Mercator Institute for China Studies, a Berlin think tank that has been ...
1 Digital China Health Technologies Corporation Limited, Beijing, China 2 ... Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China ... the proposed studies still have a few limitations. First, the privacy risk that we estimated for the case study is based on the cancer patients' data without including patients ...
Direct-to-onsumer telemedicine (DTCT) has become popular as an alternative to traditional care. However, uncertainties about the potential risks associated with the lack of comprehensive quality evaluation could influence its long-term development. This study aimed to assess the quality of care provided by DTCT platforms in China using unannounced standardised patients (USP) between July 2021 ...
The development of medical device sector in China has attracted much attention from around the world due to the nation's huge market and rising research and development (R&D) capabilities. 1,2 The sales of medical devices in China totaled no more than CNY 14.5 billion in 2000, but increased to CNY 308 billion in 2015. Since 2013, China has been ranked as the second-largest medical device ...
According to Omdia research, Chinese startups raised $1.4 billion in funding in 2020 alone, compared to their US counterparts' $2.4 billion, and the two countries accounted for 90 per cent of global investment in medical AI startups. One notable case study is the utilization of AI in cancer diagnosis at Beijing's National Cancer Center.
He received his B.S. in Computer Science and Technology from Zhejiang University in 2005, and Ph.D. in Computer Science and Technology from Zhejiang University and Imperial College London in 2010. After Ph.D., he worked as a Research Associate and then Research Fellow in the Department of Computing, Imperial College London until 2017.
China Medical Technologies, Inc. (CMED) was a Cayman Islands corporation based in China, currently in liquidation following fraud allegations. It purported to develop, manufacture, and market advanced in vitro diagnostic ("IVD") products using enhanced chemiluminescence ("ECLIA") technology, fluorescent in-situ hybridization ("FISH") technology, and surface plasmon resonance ("SPR ...
The European Union launched an investigation into China's procurement of medical devices, the latest in a spate of actions that are raising tension ahead of President Xi Jinping's first visit ...
The China Medical case is the most high-profile and closely watched contest in years over the production of Chinese audit work papers, an issue that has put Hong Kong and U.S. regulators at ...
A medical device manufacturer sharpens pricing and contracting strategies with analytics. ZS helped a multinational medical supplies manufacturer prioritize analytics in the P&C space and take advantage of deeper business insights, leading to more data-driven and effective commercial strategies to increase profitability. Read on.
According to the trade association, China is one of the major trading partners for medical equipment in Europe, making up 11% of the market's export destinations in 2022. Tough on China
A collaborative research team from Nanjing University of Science and Technology (NJUST) and East China Normal University (ECNU) has theoretically proposed that a pump-probe high-harmonic ...
Electric car sales neared 14 million in 2023, 95% of which were in China, Europe and the United States. Almost 14 million new electric cars1 were registered globally in 2023, bringing their total number on the roads to 40 million, closely tracking the sales forecast from the 2023 edition of the Global EV Outlook (GEVO-2023). Electric car sales in 2023 were 3.5 million higher than in 2022, a 35 ...